GlobalData is a publicly owned company headquartered in the UK, founded in 2010 with approximately 2,380 employees. The company provides information services, functioning as a market research provider with a focus on market sizing research.
On October 9, 2026, GlobalData reported that India’s pharmaceutical manufacturing industry is navigating a delicate phase, with growing uncertainty over its long-term access to the US market, while simultaneously improving access to other major overseas markets. Previously, on October 8, 2026, the company indicated that deal value in the pharmaceuticals industry declined by 78.8% in September 2026 compared to September 2025, with the healthcare industry reporting 85 deals worth $6.2 billion, a significant drop from the prior 12-month average of 90 deals valued at $31.8 billion. Earlier on October 8, 2026, GlobalData forecast that diagnosed prevalent cases of dyslipidemia in the 7MM are projected to increase by a 0.58% annual growth rate, from 131.6 million cases in 2025 to 139.2 million cases in 2035. Also on October 8, 2026, GlobalData projected that fixed communications service revenue in Asia-Pacific will grow at a compound annual growth rate of 2.2% between 2026 and 2031, driven by increasing fixed broadband service adoption and led by the fiber broadband segment in the region's emerging markets.
Subscribe for full access to GlobalData's products in full detail
Subscribe for full access to GlobalData's revenue in full detail
Subscribe for full access to GlobalData's products in full detail 
